drugset / Trial / NCT02097485

Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation

NCT02097485

Phase 2 Completed 50 enrolled Dr. Reddy's Laboratories Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study was to evaluate ovicidal efficacy of a single application of abametapir lotion 0.74% w/w intended for the treatment of head lice.

Timeline

Start
2014-05
Primary completion
2014-09
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Abametapir Small molecule 0.74 % Topical
Comparator Abametapir Small molecule 200 ml Topical